Hemostasis Diagnostics Market: Global Market Size, Dynamics, Growth, Regional Share, Trends, Competitor Analysis 2015 to 2020 and Forecast 2021 to 2027

$ PRICE - $ 3,000.00$ 8,900.00

Hemostasis Diagnostics Market by Product Type (Systems, Consumables, Point-of-Care Testing Devices), By Test Type (Fibrinogen Test, Activated Clotting Time, Platelet Function, Prothrombin Time, Heparin & Protamine Dose-Response Test For ACT, Activated Partial Thromboplastin Time, Anti-Factor Xa, Other Coagulation Tests), By Technology (Optical, Mechanical, Electrochemical, Others), By End-User (Hospitals, Clinics, Diagnostic Centres, Others (POC)), and Geography (Latin America, North America, Asia Pacific, Middle East & Africa and Europe)

 

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The global hemostasis diagnostics market size values USD 3.98 billion in 2020 and expected to reach USD 7.26 billion in 2027 at a CAGR of 9.1% during the forecast period 2021-2027. Hemostasis diagnostics are the devices used to determine the hemostatic defects, which cause excessive bleeding. Hemostasis is defined as the stopping or slowing the blood flow from the damaged blood vessel. During the hemostasis, blood changes from liquid state to the gelatinous state. Hemostasis maintained in the body by three mechanisms namely, blood coagulation, platelet plug formation, and vasoconstriction. Hemostasis diagnostics may help to predict the cause of bleeding during surgery by identifying the hemostatic defects in patients. Different types of tests such as prothrombin test, activated clotting time, platelet function, and other coagulation tests are carried to identify the hemostasis defects. The market is growing at a significant rate due to rise in the prevalence of trauma condition and various surgeries around the globe. Moreover, the rise in prevalence of cardiovascular diseases, cancer, and diabetes also expected to propel the market. Furthermore, acquisitions and mergers, collaborations, test approvals, and launchings are the strategies followed by the companies for increasing their revenue share. For instance, in January 2017, Instrumentation Laboratory, a subsidiary of Werfen has acquired Accriva Diagnostics for the expansion of its hemostasis testing portfolio. In addition, in June 2017, Grifols and Beckman Coulter entered into a distribution agreement for the distribution of Grifol’s hemostasis instruments, consumables, and reagents around the globe.

Hemostasis Diagnostics Market

MARKET SUMMARY
-
  • Study Period– 2021 – 2026
  • Base Year– 2020
  • CAGR– 9.1%
  • Largest Market– North America
  • Fastest Growing Market– Asia-Pacific

Hemostasis Diagnostics Market

  • The report on global hemostasis diagnostics market gives historical, current and future market sizes (US$ Bn) based on product type, end user and geographical regions.
  • hemostasis diagnostics market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Hoffmann-La Roche Ltd.
  • Sysmex Corporation
  • Abbott Laboratories
  • Nihon Kohden Corporation
  • Siemens Healthineers
  • Grifols S.A
  • Beckman Coulter, Inc.
Hemostasis Diagnostics Market

Drivers And Restraints

Increase in the incidence of blood clotting disorders such as haemophilia (according to National Hemophilia Foundation, approximately 400,000 incidences of haemophilia is observed in 2012), growing number of trauma patients and surgeries, and the introduction of biodegradable and cost-effective products are expected to propel the market growth over the forecast period. Moreover, technological advancements in the hemostasis diagnostics such as accurate results in less time, increase in awareness about the hemostasis diagnostics, and rise in R&D investment for novel tests and devices boost the market. However, the high cost of advanced hemostasis products and stringent regulations for the test approvals are expected to hamper the growth of market over the forecast period.


North-America got significant share

Hemostasis Diagnostics Market

North America hemostasis diagnostics market growing at a significant rate due to well-developed healthcare infrastructure, the rise in prevalence of cardiovascular diseases (according to Centers for Disease Control and Prevention, approximately 610,000 deaths are observed due to cardiovascular diseases every year), an increase in awareness about hemostasis diagnostics are anticipated to fuel the market. Europe market driven by adoption of newer test methods in hemostasis diagnostics, increase in the prevalence of hemostasis condition (according to The European National Registry of Congenital Coagulopathies 2017, the number of cases identified with hemostasis is increased from 7000 in 2000 to 11,000 in 2015), and changes in lifestyle leads to increase in prevalence of CVDs and diabetes, which are expected to propel the market. Asia Pacific market is growing due to increase in R&D activities in Asia Pacific countries such as Japan, and improving technical capabilities. Latin America market has a prominent growth due to increase in foreign investment, development in economic growth. Middle East and Africa market is driven by an increase in the prevalence of hemostasis and other clotting diseases in African countries.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Notable Market Developments

  • In November 2016, Siemens Healthineers launched CE-marked Atellica COAG 360 system, a high-volume speciality analyzer used in the hemostasis diagnostics

Key

Key Features of the Report

Hemostasis Diagnostics Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content

Table of Content

  1. Executive Summary
  2. Global Hemostasis Diagnostics Market Introduction
    • Global Hemostasis Diagnostics Market – Taxonomy
    • Global Hemostasis Diagnostics Market –Definitions
      • Product Type
      • Test
      • End-user
  1. Global Hemostasis Diagnostics Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Hemostasis Diagnostics Market Dynamic Factors – Impact Analysis
    • Global Hemostasis Diagnostics Market – Competition Landscape
    • Epidemiology
  2. Global Hemostasis Diagnostics Market Analysis, 2012 – 2016 and Forecast, 2018 – 2024
    • Market Analysis, 2012 – 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Hemostasis Diagnostics Market, By Product Type, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Primary Systems
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Consumables
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Point-of-Care-Testing Devices
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Hemostasis Diagnostics Market Forecast, By Test, 2013 – 2017 and Forecast, 2018 – 2024
    • Fibrinogen Test
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Activated Clotting Time
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Platelet Function
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Prothrombin Time
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Heparin & Protamine Dose-Response Test For ACT
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Activated Partial Thromboplastin Time
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Anti-Factor Xa
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Other Coagulation Tests
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Hemostasis Diagnostics Market Forecast, By Technology, 2013 – 2017 and Forecast, 2018 – 2024
    • Optical
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Mechanical
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Electrochemical
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Hemostasis Diagnostics Market Forecast, By End-user, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Hospitals
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Clinics
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Diagnostics Centers
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others (POC)
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Hemostasis Diagnostics Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Hemostasis Diagnostics Market – Opportunity Analysis Index, By Product Type, By Test, By Technology, By End-user, and Region, 2018 – 2024
  2. North America Hemostasis Diagnostics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Systems
      • Consumables
      • Point-of-Care-Testing Devices
    • Test Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Fibrinogen Test
      • Activated Clotting Time
      • Platelet Function
      • Prothrombin Time
      • Heparin & Protamine Dose-Response Test For ACT
      • Activated Partial Thromboplastin Time
      • Anti-Factor Xa
      • Other Coagulation Tests
    • Technology Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Optical
      • Mechanical
      • Electrochemical
      • Others
    • End-Users Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Diagnostic Centers
      • Others (POC)
    • Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US.
      • Canada
    • North America Hemostasis Diagnostics Market – Opportunity Analysis Index, By Product Type, By Test, By Technology, By End-user, and Country, 2018 – 2024
    • North America Hemostasis Diagnostics Market Dynamics – Trends
  3. Europe Hemostasis Diagnostics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Systems
      • Consumables
      • Point-of-Care-Testing Devices
    • Test Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Fibrinogen Test
      • Activated Clotting Time
      • Platelet Function
      • Prothrombin Time
      • Heparin & Protamine Dose-Response Test For ACT
      • Activated Partial Thromboplastin Time
      • Anti-Factor Xa
      • Other Coagulation Tests
    • Technology Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Optical
      • Mechanical
      • Electrochemical
      • Others
    • End-Users Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Diagnostic Centers
      • Others (POC)
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Hemostasis Diagnostics Market – Opportunity Analysis Index, By Product Type, By , By Test, By End-user, and Country, 2018 – 2024
    • Europe Hemostasis Diagnostics Market Dynamics – Trends
  4. Asia-Pacific Hemostasis Diagnostics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Systems
      • Consumables
      • Point-of-Care-Testing Devices
    • Test Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Fibrinogen Test
      • Activated Clotting Time
      • Platelet Function
      • Prothrombin Time
      • Heparin & Protamine Dose-Response Test For ACT
      • Activated Partial Thromboplastin Time
      • Anti-Factor Xa
      • Other Coagulation Tests
    • Technology Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Optical
      • Mechanical
      • Electrochemical
      • Others
    • End-Users Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Diagnostic Centers
      • Others (POC)
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Hemostasis Diagnostics Market – Opportunity Analysis Index, By Product Type, By Technology, By Test, By End-user, and Country, 2018 – 2024
    • Asia-Pacific Hemostasis Diagnostics Market Dynamics – Trends
  5. Latin America Hemostasis Diagnostics Market Analysis, 2012 – 2012 – 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Systems
      • Consumables
      • Point-of-Care-Testing Devices
    • Test Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Fibrinogen Test
      • Activated Clotting Time
      • Platelet Function
      • Prothrombin Time
      • Heparin & Protamine Dose-Response Test For ACT
      • Activated Partial Thromboplastin Time
      • Anti-Factor Xa
      • Other Coagulation Tests
    • Technology Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Optical
      • Mechanical
      • Electrochemical
      • Others
    • End-Users Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Diagnostic Centers
      • Others (POC)
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Hemostasis Diagnostics Market – Opportunity Analysis Index, By Product Type, By Technology, By Test, By End-user, and Country, 2018 – 2024
    • Latin America Hemostasis Diagnostics Market Dynamics – Trends
  6. Middle East and Africa Hemostasis Diagnostics Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Systems
      • Consumables
      • Point-of-Care-Testing Devices
    • Test Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Fibrinogen Test
      • Activated Clotting Time
      • Platelet Function
      • Prothrombin Time
      • Heparin & Protamine Dose-Response Test For ACT
      • Activated Partial Thromboplastin Time
      • Anti-Factor Xa
      • Other Coagulation Tests
    • Technology Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Optical
      • Mechanical
      • Electrochemical
      • Others
    • End-Users Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Diagnostic Centers
      • Others (POC)
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Hemostasis Diagnostics Market – Opportunity Analysis Index, By Product Type, By Technology, By Test, By End-user, and Country, 2018 – 2024
    • MEA Hemostasis Diagnostics Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Product Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
    • Hoffmann-La Roche Ltd. (Switzerland)
    • Sysmex Corporation (Japan)
    • Abbott Laboratories (U.S.)
    • Alere Inc.  (U.S.)
    • Nihon Kohden Corporation (Japan)
    • Siemens Healthineers (Germany)
    • Grifols S.A (Spain)
    • Beckman Coulter, Inc. (U.S.)
  8. Research Methodology
  9. Key Assumptions and Acronyms

 

Disclaimer

The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.


Report

Company Profile

  • Hoffmann-La Roche Ltd. (Switzerland)
  • Sysmex Corporation (Japan)
  • Abbott Laboratories (U.S.)
  • Alere Inc.  (U.S.)
  • Nihon Kohden Corporation (Japan)
  • Siemens Healthineers (Germany)
  • Grifols S.A (Spain)
  • Beckman Coulter, Inc. (U.S.)

Report

Ask An Analyst

 

Description

The global hemostasis diagnostics market size values USD 3.98 billion in 2020 and expected to reach USD 7.26 billion in 2027 at a CAGR of 9.1% during the forecast period 2021-2027. Hemostasis diagnostics are the devices used to determine the hemostatic defects, which cause excessive bleeding. Hemostasis is defined as the stopping or slowing the blood flow from the damaged blood vessel. During the hemostasis, blood changes from liquid state to the gelatinous state. Hemostasis maintained in the body by three mechanisms namely, blood coagulation, platelet plug formation, and vasoconstriction. Hemostasis diagnostics may help to predict the cause of bleeding during surgery by identifying the hemostatic defects in patients. Different types of tests such as prothrombin test, activated clotting time, platelet function, and other coagulation tests are carried to identify the hemostasis defects. The market is growing at a significant rate due to rise in the prevalence of trauma condition and various surgeries around the globe. Moreover, the rise in prevalence of cardiovascular diseases, cancer, and diabetes also expected to propel the market. Furthermore, acquisitions and mergers, collaborations, test approvals, and launchings are the strategies followed by the companies for increasing their revenue share. For instance, in January 2017, Instrumentation Laboratory, a subsidiary of Werfen has acquired Accriva Diagnostics for the expansion of its hemostasis testing portfolio. In addition, in June 2017, Grifols and Beckman Coulter entered into a distribution agreement for the distribution of Grifol’s hemostasis instruments, consumables, and reagents around the globe.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX